Skip to content

Clinical trials

Communicable Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Communicable Diseases Country / region: France Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20093
20121
20141
20161
20171
20182
20195
20203
20212
20227
20233
20244
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting11
Unknown status5
Not yet recruiting3
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris8
Institut National de la Santé Et de la Recherche Médicale, France4
University Hospital, Toulouse2
ANRS, Emerging Infectious Diseases1
Aix Marseille Université1
Assistance Publique Hopitaux De Marseille1
AusperBio Therapeutics Inc.1
Bledina1
Central Hospital, Nancy, France1
Centre Hospitalier Annecy Genevois1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Communicable Diseases42
Infections3
Communicable Diseases, Emerging2
Community-Acquired Pneumonia2
Urinary Tract Infections2
Virus Diseases2
Blood-Borne Infections1
COVID-191
Cardiovascular Diseases1
Cat-Scratch Disease1

Trials

Showing 76 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.